Molecular Epidemiology of Group A Streptococcus Infections in The Gambia.
Jabang, Sona
; Erhart, Annette; Darboe, Saffiatou; Baldeh, Aru-Kumba; Delforge, Valerie; Watson, Gabriella; Foster-Nyarko, Ebenezer; Salaudeen, Rasheed; Lawal, Bolarinde; Mackenzie, Grant; +4 more...Botteaux, Anne; Antonio, Martin; Smeesters, Pierre R; and On Behalf Of The Mrcg StrepA Study Group
(2021)
Molecular Epidemiology of Group A Streptococcus Infections in The Gambia.
Vaccines, 9 (2).
p. 124.
DOI: 10.3390/vaccines9020124
; Erhart, Annette; Darboe, Saffiatou; Baldeh, Aru-Kumba; Delforge, Valerie; Watson, Gabriella; Foster-Nyarko, Ebenezer; Salaudeen, Rasheed; Lawal, Bolarinde; Mackenzie, Grant; +4 more...Botteaux, Anne; Antonio, Martin; Smeesters, Pierre R; and On Behalf Of The Mrcg StrepA Study Group
(2021)
Molecular Epidemiology of Group A Streptococcus Infections in The Gambia.
Vaccines, 9 (2).
p. 124.
DOI: 10.3390/vaccines9020124
Molecular epidemiological data on Group A Streptococcus (GAS) infection in Africa is scarce. We characterized the emm-types and emm-clusters of 433 stored clinical GAS isolates from The Gambia collected between 2004 and 2018. To reduce the potential for strain mistyping, we used a newly published primer for emm-typing. There was considerable strain diversity, highlighting the need for vaccine development offering broad strain protection.
-
picture_as_pdf - Gambia_GAS_molecular_Jabang_Vaccines21.pdf
-
subject - Published Version
-
- Available under Creative Commons: Attribution-NonCommercial-No Derivative Works 3.0
Downloads